Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspectiveImmunogenic cell deathImmunotherapyLung cancerNSCLCCALRETICULIN EXPOSURECHEMOTHERAPEUTIC-AGENTSADJUVANT CHEMOTHERAPYCANCERMECHANISMSAPOPTOSISThe prevalence of non-small-cell lung cancer (NSCLC) ...
Right: Calculated average organoid area of PDAC-1 and PDAC-2. d Tumor volume of transfected PDAC-1 and PDAC-2 through subcutaneous injection of vector or N1DARP. e Left: Calcein-AM/PI staining visualized by fluorescence microscopy detecting apoptotic cells of PDAC-1 and PDAC-2 organoid with ...
其涵義如下: /0:Benign良性 /1:Uncertain behavior benign or malignant 不能確定為良性或惡性 Borderline malignancy 惡性邊緣 腫瘤分類代碼-2 /2:Carcinoma in situ;Noninvasive 原位癌或非侵犯性的 /3:Malignant;primary 惡性、原發癌 /6:Malignant;metastatic site secondary 惡性、轉移性癌 /9:Unspecified 惡性...
其涵義如下: /0:Benign良性 /1:Uncertain behavior benign or malignant 不能確定為良性或惡性 Borderline malignancy 惡性邊緣 腫瘤分類代碼-2 /2:Carcinoma in situ;Noninvasive 原位癌或非侵犯性的 /3:Malignant;primary 惡性、原發癌 /6:Malignant;metastatic site secondary 惡性、轉移性癌 /9:Unspecified 惡性...